Peer-reviewed veterinary case report
How vets diagnose chronic gut problems in dogs
By Allenspach, Karin & Mochel, Jonathan P.·Published in Veterinary Clinical Pathology·2021·Department of Veterinary Clinical Sciences College of Veterinary Medicine Iowa State University Ames IA USA, United States·View original on Crossref →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Current diagnostics for chronic enteropathies in dogs
- Species:
- dog
Plain-English summary
A dog with chronic diarrhea was evaluated for ongoing gastrointestinal issues that weren't responding to standard treatments. The vet considered different types of chronic enteropathies (CEs), which can be caused by food, antibiotics, or steroids. Diagnosing these conditions can be lengthy and costly, often requiring special tests and biopsies to rule out other causes. New tests are being developed to help predict which treatment will work best for dogs with CEs. While the study discusses these advancements, it doesn't provide specific outcomes for individual dogs.
People also search for: dog chronic diarrhea treatment · dog gastrointestinal issues tests · food-responsive enteropathy in dogs
Abstract
AbstractChronic enteropathies (CEs) in dogs describe a group of idiopathic disorders characterized by chronic persistent or recurrent gastrointestinal (GI) signs. Three major subgroups of CE can be identified by their response to treatment: Food‐responsive disease (FRD), antibiotic‐responsive disease (ARD), and steroid‐responsive disease (SRD). The clinical diagnosis of CE is made by exclusion of all other possible causes of chronic diarrhea and includes histologic assessment of intestinal biopsies. The process of diagnosing canine CE can therefore be very time‐consuming and expensive, and in most cases, does not help to identify dogs that will respond to a specific treatment. The development of novel diagnostic tests for canine CE has therefore focused on the accuracy of such tests to predict treatment responses. In this article, several novel assays that have the potential to become commercially available will be discussed, such as genetic tests, perinuclear anti‐neutrophil cytoplasmic antibodies (pANCA), antibodies against transglutaminase/gliadin, antibodies against E coli OmpC/flagellin, and micro RNAs.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on Crossref: https://doi.org/10.1111/vcp.13068